Cross-Sector entity
Weiss Ratings is the most frequent co-covered peer, appearing in 7 of the 13 tracked stories. earnings accounts for 8 of the 13 tracked stories, while 4 other categories carry the remainder. Across a 61-day span, the pace is roughly 1.5 stories per week. The busiest single day carried 2.
13 verified stories tracked
Last mentioned: 1d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 8 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Weiss Ratings is the most frequent co-covered peer, appearing in 7 of the 13 tracked stories. earnings accounts for 8 of the 13 tracked stories, while 4 other categories carry the remainder. Across a 61-day span, the pace is roughly 1.5 stories per week. The busiest single day carried 2. Zacks appears in 13 tracked Cross-Sector stories published from July 15, 2026 through September 13, 2026. Each carries 2 original sources on average. Negative sentiment appears in 0% of the tracked stories.
Computed from the 13 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Zacks. Shared-story counts are live from our verified record — not editorial picks.
COO opens near 52-week low
Stock opens at $54.17, below 50-day and 200-day moving averages and near the $51.01 low.
Cooper Companies reports Q3 FY2026 earnings
EPS of $1.15 beats consensus by $0.03; revenue of $1.07B misses the $1.10B estimate; Q4 and full-year guidance issued.
COO stock falls on heavy volume
Shares decline $4.21 to $63.48 with volume of 8.38 million shares, more than triple the average.
Q2 2026 Earnings Release
Home BancShares reports Q2 EPS of $0.64, beating consensus of $0.62; stock rises 1%.
Dividend Payment
Quarterly dividend of $0.21 per share paid to shareholders of record on May 13.
Weiss Ratings Downgrades
Weiss Ratings downgrades Home BancShares from Buy (B-) to Hold (C+).
Cantor Fitzgerald Reiterates Neutral
Cantor Fitzgerald reiterates a Neutral rating and lowers price target to $30 from $31.
Dividend Record Date
Stockholders of record as of this date eligible for $0.21 quarterly dividend; also ex-dividend date.
Stephens Lowers Price Target
Stephens cuts Home BancShares price target from $34 to $32, maintaining an Overweight rating.
Medical device maker Cooper Companies posted Q3 FY2026 EPS of $1.15, topping the $1.12 consensus, but revenue of $1.07B fell short of the $1.10B estimate. For healthcare executives, the mixed print highlights margin strength against slowing top-line growth in the device sector.
Cooper Companies reported Q3 FY2026 EPS of $1.15, beating consensus by $0.03, yet revenue of $1.07B missed the $1.10B estimate and shares dropped to a $54.17 open. For investors, the stock's heavy volume sell-off and guidance are key signals.
Source: tickerreport.com · themarketsdaily.com
Descartes Systems Group reported quarterly revenue of $198.12 million, up 11.8% year over year and ahead of consensus by $0.57 million, with EPS of $0.57 in line. The supply chain software provider's 23.35% net margin shows steady demand for logistics technology.
The logistics SaaS provider met EPS expectations at $0.57 and grew revenue 11.8% YoY to $198.12 million, but shares fell 2.9% as a 35.66 P/E leaves little room for in-line quarters. Descartes' 23.35% net margin underscores the profitability of its cloud platform.
Source: MarketBeat · tickerreport.com
Two micro-caps reported late-August earnings: biotech I-Mab posted $(0.16) EPS while CreditRiskMonitor posted $(0.04) EPS on $5.17M revenue. Divergent risk profiles—1.47 beta vs 0.22 beta—highlight small-cap earnings dynamics.
I-Mab, a clinical-stage oncology and immunology biotech, reported a $(0.16) quarterly EPS on Aug 20. With shares at $1.91, H.C. Wainwright's reiterated $9 target implies massive upside, though Weiss remains bearish. Institutional ownership sits at 38.38%.
Source: Bbns · Ticker Report
Seneca Foods posted a top-line beat of $405.17M, 24% above estimates, despite a $0.07 EPS miss, driving a 7.4% stock surge and Strong Buy ratings. Talkspace, meanwhile, missed on both EPS and revenue, but its stock held steady as institutional investors continued accumulating shares.
Source: themarketsdaily.com · dailypolitical.com
Atlanticus Holdings (ATLC) delivered a $2.50 EPS, beating by $0.08, on solid profitability metrics. Simultaneously, insiders including the CFO sold $7.87 million in shares, raising questions about alignment. With a P/E of 16.69 and beta of 2.11, the stock remains a volatile play in consumer credit.
Aligos Therapeutics (ALGS) handily beat Q2 consensus earnings per share by $0.95, a significant outperformance for the clinical-stage biotech. This beat may reflect operational efficiencies, milestone payments, or clinical progress in its liver disease pipeline. Investors in the biotech space should watch for full financial disclosures to gauge the sustainability of this positive surprise.
Source: dailypolitical.com · themarketsdaily.com
CPKC's Q2 earnings beat, with revenue up 12.6% to $2.93 billion, highlights robust cross-border rail demand. For supply chain professionals, the performance reflects strong trade flows and network integration benefits post-merger.
Canadian Pacific Kansas City posted a $0.03 EPS beat and 12.6% revenue growth, maintaining strong margins. With a consensus Buy rating and price targets as high as $105, the stock offers a defensive growth story for investors.
Source: themarketsdaily.com · dailypolitical.com
Home BancShares delivered a $0.64 per share Q2 profit, edging past consensus by $0.02. The bank's 32.48% net margin and conservative balance sheet keep it as a defensive play in a shaky regional banking sector. With a P/E of 12 and a 2.9% dividend yield, HOMB offers income and value in a stock that barely moved on the beat.
Source: MarketBeat · Zacks
Aehr Test Systems reported Q4 earnings of $0.05 per share, beating the consensus estimate of -$0.01 by $0.06. Despite negative net margins of -25.23% and insider selling, shares surged 5.9% to $72.01, with analysts mixed — two buys, one hold, one sell, and a Hold consensus with a $68 target.
Source: MarketBeat · tickerreport.com
